Company Overview and News

 
SBI, HPCL, IOC, Cipla, Dr Reddy’s, Bosch results

16h thehindubusinessline
Close to 60 companies including Andhra Bank, Allcargo, Bata India, Batliboi, Ballarpur, Bemco Hydraulics, Bosch, Bharat Forge, Capital Trust, CARE, Cipla, Dr Reddy’s Laboratories, GE Power, Future Consumer, HPCL, Igarashi Motors, IOC, Jamna Auto, L&T Technology, Minda Industries, SBI, Sonata Soft, Sundaram Clayton, Symphony, TVS Srichakra, Triveni Turbine and VIP Industries will declare their quarterly and full-year results for the period ended March 2018 on Tuesday.

 
JJ Exporters Limited

16h thehindubusinessline
The Board of JJ Exporters will meet on May 30 to consider the audited financial results of the company and consolidated results of the company under Ind AS for the year ended March 31, 2018. The board will also discuss winding up of the company and approve notice of postal ballot for winding up of the company. Shares of JJ Exporters slumped 4.9 per cent at ₹4.07 on the BSE.

 
Coastal Corp to turn ex-bonus on Wednesday

16h thehindubusinessline
Shares of Coastal Corporation will turn ex-bonus on Wednesday. The company is rewarding its shareholders with three bonus shares for every one held. Investors wishing to receive the bonus shares need to own the company's shares by Tuesday, as the company has fixed the record date as May 24 (Thursday). Earlier in 2015, Coastal Corporation had rewarded its shareholders with 1:1 bonus. Currently, a little over 1,022 retail investors hold 21.

 
Broker’s Call: JK Cement (Buy)

16h thehindubusinessline
JK Cement (JKC) is one of our top picks in our active coverage universe as we believe JKC to witness healthy traction ahead on the back of sustained growth from its value added products and likely realisation recovery for grey cement operation.

 
Rail Vikas Nigam gets SEBI’s nod to launch IPO

18h thehindubusinessline
State-run Rail Vikas Nigam Ltd (RVNL) has received capital markets regulator SEBI’s go-ahead to float an initial public offering.

 
Podcast | Sensex cracks over 200 points; mid smallcaps biggest casualty

19h moneycontrol
The S&P BSE Sensex which started on a positive note on Monday failed to hold on to momentum and turned negative for the fifth consecutive day in a row. The Nifty50 which broke below its crucial support placed at 10,550 managed to hold on to 10,500 towards the close.

 
Strides Shasun extends losses on disappointing Q4

20h thehindubusinessline
Shares in pharmaceutical company Strides Shasun Ltd slipped for a second session. They fell as much as 8.7 per cent to Rs 353.40, the lowest since April 2014.

 
Nifty corrects for 5th day, Sensex sheds 232 pts; Nifty Midcap dives 321 pts amid weak earnings

20h moneycontrol
The market extended losses for fifth consecutive session on Monday despite positive global cues, as the Sensex fell more than 200 points amid weak midcap companies' earnings. Higher crude oil prices and weaker rupee also dented sentiment.

 
Closing Bell: Sensex corrects 232 pts, Nifty Midcap sheds 321 pts amid Q4 earnings

21h moneycontrol
Market Update: Benchmark indices ended lower for the fourth consecutive session, dragged by pharma, metals, auto stocks, HDFC twins and Reliance Industries.

 
NSE to delist Kingfisher, Plethico Pharma, 16 others from May 30

23h thehindubusinessline
Leading stock exchange NSE has decided to delist Vijay Mallya-promoted Kingfisher Airlines, Plethico Pharmaceuticals and 16 other companies from May 30. This comes after BSE delisted over 200 companies from May 11 as trading in their shares remained suspended for over six months.

 
Market Update: 231 stocks hit new 52-week lows as midcaps bleed; JP Associates tanks 15%

23h moneycontrol
The market was trading flat on Monday afternoon, with the Nifty down 59 points at 10,536 and the Sensex down 152 points at 34,695.

 
Jaiprakash Associates plunges 29.5%, the most in nearly 3 years

2018-05-21 thehindubusinessline
Shares of infrastructure company Jaiprakash Associates Ltd slumped as much as 29.51 per cent in their biggest percentage loss since June 2015.

 
Amara Raja Batteries sees worst day since Nov 2016

2018-05-21 thehindubusinessline
Shares of Amara Raja Batteries Ltd slid as much as 9.1 per cent to Rs 756.45, the biggest intra-day percentage loss since November 15, 2016. The stock hit its lowest level since February 6.

 
Market Live: Sensex falls 200 pts, Midcap underperforms; Avenue Supermarts dips further

2018-05-21 moneycontrol
Buzzing: Shares of Dilip Buildcon fell 5.6 percent intraday as company's promoters pledged their shares with RBL Bank.

 
Nomura retains buy on Amara Raja Batteries; stock tanks 6% after mixed Q4 numbers

2018-05-21 moneycontrol
Shares of Amara Raja Batteries were trading lower by over 6 percent after the company reported a mixed bag of numbers on May 18, 2018. The company reported strong revenues which was in line with estimates.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

14h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

14h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...